Investigator Sponsored Studies, grants and sponsorships
Vertex Pharmaceuticals supports independent research and education focused on cystic fibrosis, pain, sickle cell disease, IgA nephropathy, and related serious diseases.
Funder: Vertex Pharmaceuticals
Due Dates: Rolling (Investigator Sponsored Studies, Grants, Sponsorships) | 2026 (Next cycle for Circle of Care, CF Research Innovation Awards, Vertex Innovation Awards)
Funding Amounts: No strict cap for most programs; CF Research Innovation Awards: up to $750,000 (3 years, independent) or $125,000 (2 years, mentored); Vertex Innovation Awards: up to $750,000/project.
Summary: Supports independent research, education, and sponsorships focused on cystic fibrosis, pain, sickle cell disease, IgA nephropathy, and related areas.
Key Information: Most programs accept rolling submissions; some competitive CF awards open next in 2026.
Description
Vertex Pharmaceuticals provides funding for a range of programs to advance health care professional education, scientific research, innovation, and community initiatives, with a strong emphasis on cystic fibrosis and other serious diseases within its research focus. Funding is available for investigator-sponsored studies (ISS), independent medical and patient education, organizational sponsorships, and select competitive research awards in cystic fibrosis. The company’s support aims to improve care, outcomes, and scientific understanding of key diseases, particularly those aligned with Vertex’s therapeutic interests.
